Jeffrey Bluestone is Director of GILEAD SCIENCES, INC.. Currently has a direct ownership of 5,708 shares of GILD, which is worth approximately $439,573. The most recent transaction as insider was on May 05, 2022, when has been sold 2,444 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.71K
0% 3M change
0% 12M change
Total Value Held $439,573

Jeffrey Bluestone Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 05 2022
BUY
Grant, award, or other acquisition
-
2,444 Added 29.98%
5,708 Common Stock
May 03 2022
BUY
Exercise of conversion of derivative security
-
2,223 Added 40.51%
3,264 Common Stock
Dec 08 2021
BUY
Exercise of conversion of derivative security
-
1,041 Added 50.0%
1,041 Common Stock

Also insider at

PRVB
Provention Bio, Inc. Healthcare
JB

Jeffrey Bluestone

Director
Foster City, CA

Track Institutional and Insider Activities on GILD

Follow GILEAD SCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GILD shares.

Notify only if

Insider Trading

Get notified when an Gilead Sciences, Inc. insider buys or sells GILD shares.

Notify only if

News

Receive news related to GILEAD SCIENCES, INC.

Track Activities on GILD